NetraMark will be attending the American Society for Clinical Psychopharmacology (ASCP) annual meeting at the Loews Miami Beach Hotel in Miami, Florida, from May 26 to 29, 2026.
This meeting gathers clinicians, investigators, researchers, and regulatory agency representatives to network and discuss neuropsychiatric drug development, pharmacogenetics, regulatory issues, and personalized interventions. See our participation activities and set up time to chat with our attending team below!
Plenary Panel
Thursday, May 28, 2026
4:30 PM – 6:00 PM
Artificial Intelligence: Understanding the Present and Anticipating the Future
Speaker: Dr. Joseph Geraci, PhD
Bridging AI Innovation and Clinical Trial Data in Psychiatry: Mathematical Limits and Clinical Consequences
Poster Presentation
Wednesday, May 27, 2026
11:45 AM – 1:30 PM
W51: Multimodal Identification of Neurobiological Subtypes Associated With Ketamine Response in Treatment-Resistant Depression Using NetraAI
Presenter: Dr. Jan Sedway, PhD
Poster Presentation
Thursday, May 28, 2026
11:30 AM – 1:15 PM
T62: Cross Trial Identification of a Predictive Enrichment Subgroup for Esmethadone (REL 1017) in Major Depressive Disorder Using Explainable Machine Learning
Presenter: Dr. Jan Sedway, PhD
Attending Team
Dr. Joseph Geraci, PhD
Chief Technical and Scientific Officer
Dr. Jan Sedway, PhD
Senior VP, Clinical Science
Josh Spiegel
President